궤양성 대장염 임상시험 결과
-
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
-
GI Permeability Change in Response to Aquamin®
-
A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative Coliti
-
A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
-
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely A
-
Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Ethnicity in the Treatment of UC
-
ENhanced Recovery in CHildren Undergoing Surgery
-
Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis
-
Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis
-
Open-label Extension Study of Brazikumab in Ulcerative Colitis
-
A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe
-
Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
-
A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis
-
Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
-
A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis
질환별 임상
폐암비소세포폐암유방암대장암위암간암췌장암전립선암난소암흑색종백혈병림프종다발성 골수종교모세포종제2형 당뇨병비만고혈압심부전심방세동뇌졸중만성 콩팥병비알코올 지방간염알츠하이머병파킨슨병다발성 경화증우울증뇌전증루게릭병류마티스 관절염건선아토피 피부염크론병궤양성 대장염루푸스천식만성폐쇄성폐질환